Cargando…

Effect of 0.01% Atropine on Accommodation in Myopic Teenagers

Purpose: The purpose of the study is to evaluate the effects of 0.01% atropine eye drops on accommodative system parameters among teenagers with low myopia. Methods: Ninety-five myopic teenagers [39 boys (8.69 ± 2.473) and 56 girls (8.54 ± 2.054) aged 5–17 years] with no history of eye disease were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huixia, Zhang, Liying, Tian, Hong, Zhang, Song, Zhang, Xueyan, Zhang, Han, Chen, Yujing, Qi, Wenping, Wu, Xiaoying, Jiang, Hongmei, Yang, Hailong, Yang, Yajun, Liu, Lei, Zhang, Guisen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861529/ https://www.ncbi.nlm.nih.gov/pubmed/35211016 http://dx.doi.org/10.3389/fphar.2022.808440

Ejemplares similares

Characteristics of responders to atropine 0.01% as treatment in Asian myopic children
por: Lee, Lung-Chi, et al.
Publicado: (2022)

Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination
por: Hao, Qian, et al.
Publicado: (2021)

Role of 0.01% atropine in high myopic children of Moradabad, India (RAMCOM Study)
por: Agarwal, Pradeep, et al.
Publicado: (2022)

Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine
por: Tan, Qi, et al.
Publicado: (2023)

Effect of atropine 0.01% on progression of myopia
por: Sen, Snigdha, et al.
Publicado: (2022)

Compounded 0.01% Atropine—What's in the Bottle?
por: Richdale, Kathryn, et al.
Publicado: (2023)

Effectiveness of 0.01% atropine in anisomyopic children
por: Hussain, Azfira, et al.
Publicado: (2023)

Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis
por: Tsai, Hou-Ren, et al.
Publicado: (2021)

Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
por: Jethani, Jitendra, et al.
Publicado: (2021)

Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Short-Term Effects of Atropine 0.01% on the Structure and Vasculature of the Choroid and Retina in Myopic Chinese Children
por: Wang, Yuliang, et al.
Publicado: (2022)

The Effects of 0.01% Atropine on Adult Myopes’ Contrast Sensitivity
por: Cheng, Ziyun, et al.
Publicado: (2021)

Use baseline axial length measurements in myopic patients to predict the control of myopia with and without atropine 0.01%
por: Rose, Loreto V. T., et al.
Publicado: (2021)

Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Patil, Ankita A, et al.
Publicado: (2022)

Response to comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control
por: Zhang, Xiaoyu, et al.
Publicado: (2020)

Effects of atropine 0.01% on refractive errors in children with myopia
por: Zhu, Xingxue, et al.
Publicado: (2023)

Clinical efficacy of 0.01% atropine in retarding the progression of myopia in children
por: Zhao, Qi, et al.
Publicado: (2020)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

A multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2021)

The Effect of 0.01% Atropine Eye Drops on the Ocular Surface in Children for the Control of Myopia—The Primary Results from a Six-Month Prospective Study
por: Cheng, Jingyi, et al.
Publicado: (2020)

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: The Atropine for Children and Adolescent Myopia Progression Study
por: Ye, Luyao, et al.
Publicado: (2022)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2022)

A Pilot Study on the Efficacy and Safety of 0.01% Atropine in German Schoolchildren with Progressive Myopia
por: Joachimsen, Lutz, et al.
Publicado: (2019)

Response to comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2020)

Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2023)

A Randomized Controlled Trial of the Effect of 0.01% Atropine Eye Drops Combined with Auricular Acupoint Stimulation on Myopia Progression
por: Kong, Xie-He, et al.
Publicado: (2021)

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns
por: Erdinest, Nir, et al.
Publicado: (2022)

The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis
por: Wang, Zengying, et al.
Publicado: (2023)

Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report
por: Yan, Chunxiao, et al.
Publicado: (2023)

Add-On Effect of 0.01% Atropine in Orthokeratology Wearers for Myopia Control in Children: A 2-Year Retrospective Study
por: Du, Linlin, et al.
Publicado: (2023)

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial
por: Cui, Can, et al.
Publicado: (2021)

Effects of 0.01% Atropine Instillation Assessed Using Swept-Source Anterior Segment Optical Coherence Tomography
por: Mitsukawa, Tadahiro, et al.
Publicado: (2021)

Efficacy of 0.01% low dose atropine and its correlation with various factors in myopia control in the Indian population
por: Chaurasia, Shweta, et al.
Publicado: (2022)

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia
por: Kothari, Mihir, et al.
Publicado: (2020)

Efficacy of 0.01% atropine for myopia control in a randomized, placebo-controlled trial depends on baseline electroretinal response
por: Chan, Henry H. L., et al.
Publicado: (2022)

The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis
por: Gao, Yue, et al.
Publicado: (2022)

Effect of atropine 0.01% on myopia control in children aged 6–13 years during the 2022 lockdown in Shanghai
por: Yu, Manrong, et al.
Publicado: (2023)

Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression
por: Pérez-Flores, Inés, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b2j164q48hketkt61snqlrdki1